Literature DB >> 19472035

Polymyositis and myocarditis after donor lymphocyte infusion.

Jae-Sook Ahn1, Sang-Hee Cho1, Yeo-Kyeoung Kim1, Deok-Hwan Yang1, Woo Kyun Bae1, Hyun Jeong Shim1, Je-Jung Lee1, Ik-Joo Chung1, Sang Woo Juhng2, Hyeoung-Joon Kim3.   

Abstract

Chronic graft versus host disease (GVHD) is a common late complication of hematopoietic stem cell transplantation. Polymyositis is a rare manifestation of chronic GVHD after donor lymphocyte infusion (DLI). Patients with both polymyositis and myocarditis have not been reported to date. Here, we report an 18-year-old female patient who developed polymyositis and myocarditis after a DLI. The patient developed the symptoms of fever, generalized myalgia, dysarthria, and asymptomatic sinus tachycardia at DLI day +102, and 17 days after the discontinuation of immunosuppressants. The laboratory testing showed elevated muscle enzymes, and the electromyographic examination revealed myopathic abnormalities compatible with the diagnosis of myositis. The muscle biopsy showed CD8+ T cell infiltration of the muscle fibers. The electrocardiogram (ECG) showed sinus tachycardia with an incomplete right bundle branch block, anteroseptal ST elevation and lateral ST depression. Echocardiography showed mild hypokinesia of the left interventricular septal wall without evidence of infection or leukemic relapse. The patient was immediately treated with 60 mg/day of prednisone and tacrolimus after the diagnosis of polymyositis and myocarditis, apparently associated with chronic GVHD. The cardiac and muscle enzymes decreased and the ECG normalized after immunosuppressant treatment. The follow-up ECG 2 weeks after initiation of therapy was normal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19472035     DOI: 10.1007/s12185-009-0332-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  14 in total

1.  Fatal giant cell myocarditis after allogeneic bone marrow transplantation.

Authors:  M Yabe; H Ishiguro; Y Yasuda; I Takakura; S Matsuda; K Shimamura; S Kato; H Yabe
Journal:  Bone Marrow Transplant       Date:  2007-10-15       Impact factor: 5.483

Review 2.  Diagnosis and treatment of chronic graft-versus-host disease.

Authors:  Andrew L Gilman; Jonathan Serody
Journal:  Semin Hematol       Date:  2006-01       Impact factor: 3.851

3.  Complete heart block due to interleukin-2 therapy.

Authors:  P T Vaitkus; D Grossman; K R Fox; M D McEvoy; J U Doherty
Journal:  Am Heart J       Date:  1990-04       Impact factor: 4.749

4.  Cardiac manifestations of graft-versus-host disease.

Authors:  Cynthia Rackley; Kirk R Schultz; Frederick D Goldman; Ka Wah Chan; Amy Serrano; James E Hulse; Andrew L Gilman
Journal:  Biol Blood Marrow Transplant       Date:  2005-10       Impact factor: 5.742

5.  Myositis as a manifestation of chronic graft-versus-host disease.

Authors:  K Takahashi; K Kashihara; K Shinagawa; T Yoshino; K Abe; M Harada
Journal:  Intern Med       Date:  2000-06       Impact factor: 1.271

6.  Acute polymyositis after donor lymphocyte infusion.

Authors:  Peng-Chan Lin; Liang-Tsai Hsiao; Po-Min Chen
Journal:  Eur J Haematol       Date:  2005-02       Impact factor: 2.997

Review 7.  Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.

Authors:  D R Couriel; G Z Beguelin; S Giralt; M De Lima; C Hosing; M A Kharfan-Dabaja; A Anagnostopoulos; R Champlin
Journal:  Bone Marrow Transplant       Date:  2002-10       Impact factor: 5.483

Review 8.  The role of cytokines in graft-versus-host reactions and disease.

Authors:  M R Jadus; H T Wepsic
Journal:  Bone Marrow Transplant       Date:  1992-07       Impact factor: 5.483

9.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

Review 10.  Polymyositis as a manifestation of chronic graft-versus-host disease.

Authors:  A M Stevens; K M Sullivan; J L Nelson
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

View more
  7 in total

1.  Neuromuscular complications after hematopoietic stem cell transplantation.

Authors:  Susanne Koeppen; Abhiyrahmi Thirugnanasambanthan; Michael Koldehoff
Journal:  Support Care Cancer       Date:  2014-03-29       Impact factor: 3.603

2.  Intramuscular leukemic relapse: clinical signs and imaging findings. A multicentric analysis.

Authors:  Alexey Surov; Hayyam Kiratli; Soo Ah Im; Yasuhiro Manabe; Alibhe O'Neill; Atul B Shinagare; Rolf Peter Spielmann
Journal:  Skeletal Radiol       Date:  2014-09-26       Impact factor: 2.199

Review 3.  A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.

Authors:  Fotios V Michelis; Vera Bril; Jeffrey H Lipton
Journal:  Int J Hematol       Date:  2015-03-03       Impact factor: 2.490

4.  PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.

Authors:  Kathryn W Juchem; Faruk Sacirbegovic; Cuiling Zhang; Arlene H Sharpe; Kerry Russell; Jennifer M McNiff; Anthony J Demetris; Mark J Shlomchik; Warren D Shlomchik
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

5.  Polymyositis after donor lymphocyte infusion.

Authors:  Juan Montoro; Juan Carlos Hernández-Boluda; Cristina Arbona; Carlos Solano
Journal:  Int J Hematol       Date:  2012-08-19       Impact factor: 2.490

Review 6.  Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review.

Authors:  Masahiko Sumi; Mari Kitahara; Tsutomu Shishido; Hiroko Kazumoto; Nozomu Uematsu; Takehiko Kirihara; Keijiro Sato; Toshimitsu Ueki; Yuki Hiroshima; Kunihiko Shimizu; Hikaru Kobayashi
Journal:  Intern Med       Date:  2019-08-28       Impact factor: 1.271

7.  Chronic Graft-Versus-Host-Disease-Related Polymyositis: a 17-Months-Old Child with a Rare and Late Complication of Haematopoietic Stem Cell Transplantation.

Authors:  Matteo Chinello; Rita Balter; Massimiliano De Bortoli; Virginia Vitale; Ada Zaccaron; Elisa Bonetti; Paola Tonin; Gaetano Vattemi; Valeria Guglielmi; Simone Cesaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-01-01       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.